KV Pharmaceutical Files for Chapter 11; Cites Makena Drug Woes - Wal...
08/06/12
![]()
KV Pharmaceutical Files for Chapter 11; Cites Makena Drug Woes
Wall Street Journal
By Saabira Chaudhuri. K-V Pharmaceutical Co. (KVA, KVB) filed for Chapter 11 bankruptcy, a move it said was propelled by the U.S. Food and Drug Administration's failure to enforce orphan drug exclusivity granted to K-V's key premature-birth drug, Makena.
[more]
Wall Street Journal
By Saabira Chaudhuri. K-V Pharmaceutical Co. (KVA, KVB) filed for Chapter 11 bankruptcy, a move it said was propelled by the U.S. Food and Drug Administration's failure to enforce orphan drug exclusivity granted to K-V's key premature-birth drug, Makena.
- Feeds Categories: